News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
132 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
BioCapital
Why This Maryland Biotech Could Double Its Stock by 2018
This biotech has had a year where its stock had grown 20 percent and roller-coastered down 20 percent, several times.
November 20, 2017
·
3 min read
·
Mark Terry
Drug Development
Bay Area’s PellePharm Wins FDA Breakthrough Tag for Genetic Rare Disease Drug
PellePharm is aiming to launch Phase III trials of the topical hedgehog inhibitor in early 2018.
November 20, 2017
·
2 min read
·
Alex Keown
Zensun Raises $76M for Novel Drug Portfolio
Zensun Science & Technology raised $76M from a group of investors led by SDIC Venture Capital Management, which contributed half of the funding itself.
November 20, 2017
·
1 min read
Drug Development
Acorda Takes a $363M Hit as Deaths Lead to Termination of Parkinson’s Drug
There were five fatalities out of seven patients with sepsis, all in the tozadenant group.
November 20, 2017
·
2 min read
·
Mark Terry
Business
Siemens to Slash 6,900 Jobs Worldwide
The majority of the cuts will be in Germany and about 1,800 will be in the U.S.
November 20, 2017
·
2 min read
·
Alex Keown
Drug Development
Genentech Gets a Phase III Win With Hemophila A Drug Hemlibra
Genentech announced that its Phase III HAVEN 3 study of Hemlibra in adults and adolescents with hemophilia A without inhibitors to factor VIII had positive results.
November 20, 2017
·
2 min read
·
Mark Terry
Biotech Bay
3 Top Under-the-Radar Medtech Stocks to Buy Right Now
Here’s a list of 10 medical device companies, along with their areas of focus.
November 20, 2017
·
1 min read
Drug Development
3 Top Drugmakers Leading Lung Cancer R&D Right Now
Researchers are making great headway against cancer, even though it’s currently still the second-leading cause of death in the U.S.
November 20, 2017
·
3 min read
·
Mark Terry
Drug Development
Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran
The company is weeks away from completing its rolling NDA for Patisiran.
November 20, 2017
·
2 min read
·
Alex Keown
Business
Stericycle Cuts 335 Employees in Restructuring
The company expects to spend about $7 million to $10 million on severance costs, according to the filing with the SEC.
November 20, 2017
·
1 min read
1 of 14
Next
